Advertisement
Screener

STRONGBRIDGE BIOPHARMA plc Proceeds from Warrant Exercises

STRONGBRIDGE BIOPHARMA plc Proceeds from Warrant Exercises

STRONGBRIDGE BIOPHARMA plc reported Proceeds from Warrant Exercises of $1.18 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-03-03.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromWarrantExercises · last filed 2021-03-03

  • STRONGBRIDGE BIOPHARMA plc proceeds from warrant exercises for the quarter ending 2018-12-31 was $1.00K.
  • STRONGBRIDGE BIOPHARMA plc proceeds from warrant exercises for fiscal 2018 was $1.18M.
Period endProceeds from Warrant Exercises 3 monthProceeds from Warrant Exercises 9 monthProceeds from Warrant Exercises 12 month
2018-12-31$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03
$1.18M
10-K · filed 2021-03-03
2018-09-30$1.18M
10-Q · filed 2019-11-07